v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from Operating activities    
Net loss $ (7,121) $ (8,461)
Adjustments to reconcile net loss to cash used in operating activities:    
Income from discontinued operations (249) 0
Foreign exchange transaction loss from intercompany 3,607 61
Depreciation and amortization 3,057 149
Gain on deconsolidation (19,336) 0
Non cash interest expense on debt 2,541 0
Stock-based compensation 4,412 1,890
Shares issued for non-cash consultant expense 0 247
Change in fair value of share liability 0 (12)
Change in fair value of convertible notes payable 568 957
Change in fair value of equity investments (1,126) 0
Change in right-of-use lease asset 3,293 130
Non-cash lease income (62) 0
Change in deferred taxes (76) (81)
Changes in operating assets and liabilities, net of acquisition amounts:    
Accounts receivable (800) 0
Receivable from noncontrolling interest 0 31
Inventories (208) (273)
Prepaid expenses and other current assets (739) 1,190
Other noncurrent assets (89) 39
Accounts payable (162) 1,072
Accrued expenses (1,172) 720
Operating lease liabilities (3,251) (60)
Other current liabilities (112) (769)
Other noncurrent liabilities 386 0
Net cash used in operating activities - continuing operations (16,639) (3,170)
Cash used for operating activities - discontinued operations (1,121) 0
Net cash used in operating activities (17,760) (3,170)
Cash flows from investing activities    
Purchases of property and equipment (6,137) (2,309)
Purchases of short-term investments (35,425) 0
Principal collections from lease receivable 159 0
Cash advance paid for property and equipment 0 (50)
Purchase of equity investments (10,000) 0
Cash received for acquisition of business, net of cash paid 4,919 0
Cash disposed of upon deconsolidation of subsidiary (50,699) 0
Net cash used in investing activities - continuing operations (97,183) (2,359)
Net cash used in investing activities (97,183) (2,359)
Cash flows from financing activities    
Payment of deferred issuance costs (267) 0
Proceeds from collection of receivable from noncontrolling interest in VIE 0 29
Distribution to noncontrolling interest in VIE (257) (38)
Distribution to noncontrolling interest of Renergen (380) 0
Proceeds from issuance of debt 53 46
Payment of principal portion of debt (1,823) (252)
Payment of principal portion of finance leases (44) (10)
Net cash used in financing activities - continuing operations (2,718) (225)
Cash provided by financing activities - discontinued operations 45,886 0
Net cash provided by (used in) financing activities 43,168 (225)
Net change in cash, cash equivalents and restricted cash (71,775) (5,754)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (2,044) (170)
Cash, cash equivalents and restricted cash - beginning of period 285,563 61,890
Cash, cash equivalents and restricted cash - end of period 211,744 55,966
Components of cash, cash equivalents, and restricted cash    
Cash and cash equivalents 207,346 55,966
Restricted cash 4,398 0
Total cash, cash equivalents, and restricted cash 211,744 55,966
Supplemental disclosures of non-cash investing and financing activities:    
Derecognition of asset as a result of sales-type lease 1,689 0
Unpaid financing fees 915 0
Lease receivable 1,689 0
Purchase of property and equipment included in accounts payable 1,358 466
Purchase of property and equipment with bank loans 53 47,080
Right-of-use asset obtained in exchange for operating lease liability 1,673 0
Right-of-use asset obtained in exchange for finance lease liability 341 0
Common stock issued in acquisition of Renergen 92,897 0
Noncash consideration for acquisition of Numed $ 358 $ 0